Lab
Ameripath New York, LLC
Ameripath New York, LLC was paid $1.55M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 62% of everything it billed.
33Billing provider infoAMERIPATH NEW YORK, LLC
CLIFTON, NJ 07012
CLIFTON, NJ 07012
33aNPI1366827602assigned 07/28/2015
33bProvider typeClinical Medical Laboratory
28Total paid$1.55M
24GClaims62,596
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New Jersey
Rank by total paid#60 of 122
Median peer was paid$1.29M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WHEELER, DARREN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,960 | $178K | |
| 2019 | 5,197 | $416K | |
| 2020 | 3,009 | $219K | |
| 2021 | 3,319 | $206K | |
| 2022 | 3,201 | $208K | |
| 2023 | 2,806 | $195K | |
| 2024incomplete | 2,104 | $129K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 62% | 13,545 | 12,139 | $968K |
| 88312 | 16% | 2,656 | 2,552 | $255K | |
| 88313 | 11% | 2,559 | 2,478 | $170K | |
| 88173 | 2.9% | 878 | 849 | $45K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.0% | 507 | 506 | $16K |
| 88112 | <1% | 2,698 | 2,647 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,225 | 1,210 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 755 | 465 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,221 | 1,206 | $6K |
| 87799 | <1% | 187 | 186 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 497 | 271 | $6K |
| 80050 | General health panel | <1% | 1,606 | 1,606 | $5K |
148 more codes
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 174 | $4K |
| 88304 | <1% | 254 | $2K | |
| 80061 | Lipid panel | <1% | 2,563 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 287 | $2K |
| 87512 | <1% | 185 | $2K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 41 | $2K |
| 88342 | <1% | 38 | $2K | |
| 86480 | <1% | 216 | $2K | |
| 87481 | <1% | 181 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,153 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 1,531 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,549 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 495 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 693 | $923.23 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 530 | $917.28 |
| 87070 | <1% | 565 | $885.92 | |
| 86003 | <1% | 58 | $837.49 | |
| 82607 | <1% | 675 | $648.62 | |
| 82728 | <1% | 516 | $643.95 | |
| 80074 | <1% | 92 | $599.88 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,290 | $590.33 |
| 82746 | <1% | 510 | $509.19 | |
| 86696 | <1% | 115 | $466.95 | |
| 81001 | <1% | 1,668 | $459.54 | |
| 84702 | <1% | 195 | $442.40 | |
| 84439 | <1% | 779 | $425.70 | |
| 84153 | <1% | 368 | $424.60 | |
| 83550 | <1% | 569 | $402.35 | |
| 87480 | <1% | 100 | $399.95 | |
| 87510 | <1% | 100 | $399.95 | |
| 87660 | <1% | 100 | $357.85 | |
| 87536 | <1% | 33 | $357.20 | |
| 83540 | <1% | 879 | $355.07 | |
| 83655 | <1% | 198 | $305.04 | |
| 83970 | <1% | 60 | $303.24 | |
| 87340 | <1% | 413 | $291.84 | |
| 87088 | <1% | 189 | $288.66 | |
| 84146 | <1% | 99 | $284.62 | |
| 84403 | <1% | 95 | $270.90 | |
| 82043 | <1% | 571 | $254.94 | |
| 86695 | <1% | 101 | $249.12 | |
| 87186 | <1% | 147 | $235.82 | |
| 83001 | <1% | 103 | $234.00 | |
| 82570 | <1% | 591 | $222.63 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 797 | $211.65 |
| 86592 | <1% | 508 | $210.56 | |
| 86803 | <1% | 290 | $209.58 | |
| 83021 | <1% | 74 | $208.45 | |
| 82670 | <1% | 57 | $205.24 | |
| 87077 | <1% | 131 | $203.28 | |
| 86787 | <1% | 145 | $202.78 | |
| 84144 | <1% | 45 | $197.10 | |
| 83002 | <1% | 99 | $194.30 | |
| 84402 | <1% | 34 | $187.11 | |
| 85027 | <1% | 288 | $183.06 | |
| 84480 | <1% | 237 | $178.56 | |
| 82105 | <1% | 173 | $176.00 | |
| 86317 | <1% | 231 | $173.03 | |
| 88141 | <1% | 22 | $162.00 | |
| 80081 | <1% | 12 | $157.12 | |
| 86762 | <1% | 148 | $151.89 | |
| 86735 | <1% | 138 | $150.59 | |
| 86765 | <1% | 142 | $148.72 | |
| 87081 | <1% | 262 | $145.95 | |
| 84436 | <1% | 357 | $144.20 | |
| 84481 | <1% | 134 | $142.24 | |
| 84550 | <1% | 811 | $140.29 | |
| 86706 | <1% | 204 | $135.24 | |
| 84154 | <1% | 62 | $135.10 | |
| 87517 | <1% | 108 | $134.85 | |
| 87631 | <1% | 21 | $134.62 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 143 | $133.05 |
| 82248 | <1% | 685 | $132.94 | |
| 82977 | <1% | 498 | $123.79 | |
| 85610 | <1% | 206 | $123.60 | |
| 84479 | <1% | 324 | $122.04 | |
| 82627 | <1% | 29 | $116.65 | |
| 86376 | <1% | 64 | $106.89 | |
| 83615 | <1% | 476 | $104.11 | |
| 82677 | <1% | 27 | $101.48 | |
| 85730 | <1% | 109 | $100.96 | |
| 86800 | <1% | 80 | $100.14 | |
| 86360 | <1% | 13 | $98.62 | |
| 87147 | <1% | 151 | $88.80 | |
| 86038 | <1% | 150 | $88.76 | |
| 86704 | <1% | 98 | $88.55 | |
| 82785 | <1% | 44 | $86.35 | |
| 82652 | <1% | 100 | $80.80 | |
| 84100 | <1% | 462 | $77.16 | |
| 86336 | <1% | 27 | $65.40 | |
| 83735 | <1% | 145 | $63.27 | |
| 83516 | <1% | 29 | $60.50 | |
| 80076 | <1% | 94 | $60.06 | |
| 82565 | <1% | 61 | $56.63 | |
| 86235 | <1% | 13 | $56.46 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16 | $56.28 |
| 82747 | <1% | 16 | $54.51 | |
| 86708 | <1% | 133 | $52.00 | |
| 82274 | <1% | 75 | $50.07 | |
| 82150 | <1% | 59 | $47.60 | |
| 82465 | <1% | 101 | $43.87 | |
| 83690 | <1% | 59 | $43.38 | |
| 88142 | <1% | 99 | $42.52 | |
| 86780 | <1% | 33 | $41.67 | |
| 87254 | <1% | 12 | $41.06 | |
| 82550 | <1% | 141 | $40.98 | |
| 81003 | <1% | 179 | $39.95 | |
| 82378 | <1% | 34 | $39.80 | |
| 82950 | <1% | 39 | $34.86 | |
| 86617 | <1% | 12 | $32.52 | |
| 84520 | <1% | 51 | $31.88 | |
| 85652 | <1% | 261 | $31.13 | |
| 86901 | <1% | 62 | $25.12 | |
| 84156 | <1% | 62 | $23.10 | |
| 84460 | <1% | 36 | $20.84 | |
| 82784 | <1% | 48 | $19.52 | |
| 82310 | <1% | 65 | $19.06 | |
| 86900 | <1% | 56 | $18.84 | |
| 86618 | <1% | 26 | $17.87 | |
| 85045 | <1% | 49 | $16.76 | |
| 86140 | <1% | 176 | $16.29 | |
| 87338 | <1% | 12 | $15.10 | |
| 84478 | <1% | 47 | $14.89 | |
| 86225 | <1% | 13 | $14.42 | |
| 86141 | <1% | 33 | $13.58 | |
| 83010 | <1% | 13 | $13.20 | |
| 86255 | <1% | 13 | $12.65 | |
| 87427 | <1% | 24 | $12.58 | |
| 86431 | <1% | 108 | $11.90 | |
| 86039 | <1% | 13 | $11.71 | |
| 84450 | <1% | 27 | $10.86 | |
| 87045 | <1% | 26 | $9.91 | |
| 87046 | <1% | 25 | $9.91 | |
| 82247 | <1% | 13 | $9.42 | |
| 82947 | <1% | 34 | $2.91 | |
| 83721 | 0% | 56 | $0.00 | |
| 86200 | 0% | 35 | $0.00 | |
| 86709 | 0% | 28 | $0.00 | |
| 86334 | 0% | 12 | $0.00 | |
| 83013 | 0% | 14 | $0.00 | |
| 87209 | 0% | 13 | $0.00 | |
| 87177 | 0% | 13 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 15 | $0.00 |
| 86850 | 0% | 12 | $0.00 | |
| 87650 | 0% | 39 | $0.00 | |
| 86707 | 0% | 42 | $0.00 | |
| 87350 | 0% | 41 | $0.00 | |
| 84703 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHEELER, DARREN (VICE PRESIDENT)
Parent organizationAMERIPATH, INC
| Provider | Location | Paid |
|---|---|---|
| Colorado Pathology Consultants PC | Denver, CO | $13.20M |
| Ameripath New York LLC | Shelton, CT | $7.70M |
| Ameripath New York LLC | White Plains, NY | $4.88M |
| Ameripath Hospital Services-Florida LLC | Fort Myers, FL | $3.60M |
| Ameripath Florida LLC | Pompano Beach, FL | $3.50M |
| Diagnostic Pathology Services, INC. | Oklahoma City, OK | $2.94M |
| Hoffman, MD, Associated Pathologists Chartered | Las Vegas, NV | $1.52M |
| Ameripath Cleveland INC | Twinsburg, OH | $749K |
| Ameripath Texas, INC. | Lewisville, TX | $712K |
| Institute for Dermatopathology, INC. | Newtown Square, PA | $636K |
| Ameripath Cincinnati INC | Cincinnati, OH | $603K |
| Ameripath Lubbock 501A Corporation | Lubbock, TX | $594K |
| Institute for Dermatopathology, INC. | Pittsburgh, PA | $522K |
| Ameripath Tucson INC | Tucson, AZ | $514K |
| Ameripath Kentucky INC | Lexington, KY | $458K |
| Ameripath Florida LLC | Fort Myers, FL | $415K |
| Ameripath Florida LLC | Altamonte Springs, FL | $332K |
| Dermatopathology of Wisconsin SC | Brookfield, WI | $304K |
| Phenopath Laboratories PLLC | Seattle, WA | $279K |
| Ameripath Lubbock 501A Corporation | Lubbock, TX | $186K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.